During the campaign, President Trump vowed he would “bring down drug prices” through negotiation and other means, and earlier this year repeated that promise, saying the drug companies were “getting away with murder.” Yet when the President actually met with PHRMA CEOs just a month and a half ago, he seemed to capitulate to the […]
Momentum continues to build against secretive prescription drug practices with the introduction of SB 17 (Hernandez) which is being hailed by health care consumers and labor advocates alike.
SB 1010 could have provided transparency for drug price increases like Mylan’s EpiPen, which increased 400% this week.
Big Pharma may have big money, but every voter knows someone personally concerned about the rising cost of prescription drugs. By bill or ballot measure or some other means, there has to be transparency and some relief on prescription drug prices.
Yesterday, the Assembly Health Committee passed one consumer protection measure, SB 923 (Hernandez) on a vote of 17-0, to prevent mid-year increases in co-payments and other cost-sharing by a health plan. Other key legislation also authored by Senate Health Committee Chair Dr. Ed Hernandez and sponsored by Health Access California to protect patients from unfair […]
As the April 22 policy deadline approached, all of Health Access’ priority bills made it over the finish line. Last week, the legislative committees voted on two important bills that will increase transparency in our health care system. Transparency for Prescription Drug Costs Prescription drugs are the health service most commonly used by consumers and […]
With the legislative session in full-swing, Health Access California’s bills are moving full steam ahead! Last week, SB 908 and SB 1135 both passed the Senate Health Committee. SB 1135 (Monning) helps consumers know there are time limits on how long they have to wait to get health care appointments and who to complain to if […]
Thursday’s Covered California Board meeting, the first since the last day of open enrollment 2013, offered a deep dive on the standardized benefit designs and the quality/equity framework that will guide contracting with insurers for the next 3-year cycle (2017-2019), and a heated discussion about the new documentation requirements that insurers are calling for to qualify […]
Earlier today the California Assembly Health Committee failed to pass AB 463 (Chiu), a bill introduced last session that would have required greater transparency around the pricing of high-cost medications. Bill author David Chiu pulled the bill because he did not have enough votes, like last year, to get it through committee. But, as he […]
Last month the federal Department of Health and Human Services (HHS) released a proposed rule implementing Section 1557 of the Affordable Care Act, which extends civil rights protections under Title VI, Title IX, the Age Discrimination Act, and the Americans with Disabilities Act (ADA), among others, to health programs that receive any federal funds. No […]